Oscar-winning filmmaker Guillermo del Toro was honored with SFFilm's Sloan Science in Cinema Prize for "Frankenstein," an ...

Donald Trump’s path to victory for the GOP in 2026 is clear: sustain a growing economy while facing opposition determined to ...

As the aphorism reminds us, "Beauty lies in the eyes of the beholder",—but what beauty emerges when sight falters? Or, as ...

ILTACON Europe this year largely focused on talks from great speakers who are not connected with the legal tech world but have powerful messages to share.

Editing genes in sperm, eggs and embryos is currently banned in the United States. The current effort by Preventive, a Silicon Valley startup, involves a couple with a genetic abnormality who want to ...

Sam Altman and husband reportedly working to genetically engineer babies from having hereditary disease - Sam Altman and his ...

Microrobots could be precisely directed, under clinical conditions, by integrating systems for navigation, therapeutic ...

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...

According to a Wall Street Journal report, the company Preventive is working toward genetically engineering its first baby ...

CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.

Detailed price information for Autolus Therapeutics Plc ADR (AUTL-Q) from The Globe and Mail including charting and trades.